Motus Gi Holdings stock analysis
Want to see MOTS full AI Analyst Report?
Motus Gi Holdings (MOTS) Stock Price & Analysis
MOTS Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $0.01
- Previous Close
- $0.01
- Volume
- N/A
- Average Volume (3M)
- 41.14K
- Market Cap
- $1,278
- Enterprise Value
- $1.28M
- Total Cash (Recent Filing)
- $4.94M
- Total Debt (Recent Filing)
- $2.44M
- Price to Earnings (P/E)
- 0.0
- Beta
- 413.08
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Innovative Product Offering
The Pure-Vu System enhances the efficacy of colonoscopies, potentially reducing the need for repeat procedures. This innovation can drive adoption in hospitals and clinics, supporting long-term revenue growth as the product addresses a critical need in gastrointestinal endoscopy.
Strategic Partnerships
Strategic partnerships can enhance market penetration and adoption of the Pure-Vu System. Collaborations with healthcare providers can lead to increased sales and potentially open new revenue streams, strengthening the company's market position over time.
Operational Cost Management
Improved cost management indicates the company's efforts to enhance operational efficiency. This can lead to better financial performance in the long term, as cost controls may eventually translate into improved margins and reduced losses.
Bears Say
Declining Revenue Trend
A declining revenue trend poses a significant challenge, indicating reduced market demand or competitive pressures. This trend can strain financial resources and limit growth opportunities, impacting the company's ability to invest in new initiatives or expand its market presence.
Negative Cash Flows
Negative cash flows highlight ongoing liquidity challenges and reliance on external funding. This situation can limit the company's ability to invest in growth initiatives and may necessitate further financing, increasing financial risk and potentially diluting shareholder value.
Consistent Net Losses
Persistent net losses indicate operational inefficiencies and challenges in achieving profitability. This ongoing financial instability can undermine investor confidence and limit the company's ability to attract new capital, hindering long-term growth and sustainability.
Motus Gi Holdings News
MOTS FAQ
What was Motus Gi Holdings’s price range in the past 12 months?
What is Motus Gi Holdings’s market cap?
When is Motus Gi Holdings’s upcoming earnings report date?
How were Motus Gi Holdings’s earnings last quarter?
Is Motus Gi Holdings overvalued?
Does Motus Gi Holdings pay dividends?
What is Motus Gi Holdings’s EPS estimate?
How many shares outstanding does Motus Gi Holdings have?
What happened to Motus Gi Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Motus Gi Holdings?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Motus Gi Holdings
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mark Pomeranz
- Employees
- 15
- Website
- www.motusgi.com
- Address
- 1301 East Broward Boulevard, Fort Lauderdale, FL, 33301, US










